Pancreatic Cancer Research

ResearcherUniversity of CologneActive in the last 2 years

Jiangang Zhao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108581516. Sources: OpenAlex.

Their work

Papers
14
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 5 papers · 2026: 4 papers

Papers 14

  1. Lactate-associated gene PLAU promotes liver metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.compbiolchem.2026.109075↗
  2. Targeting CYBA inhibits hepatic metastasis of pancreatic cancer through AKT/MLC2 pathway. Co-author DOI 10.1038/s41401-026-01880-z↗
  3. LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming. Co-author DOI 10.1038/s41419-026-09075-4↗
  4. Immune-Mitochondrial Crosstalk in Pancreatic Adenocarcinoma: Systematic Identification of Prognostic Biomarkers Through Immune Dictionary Framework Co-author DOI 10.2174/0118715303422686250925054821↗
  5. Strand-specific functions of miR-301a-3p and -5p drive opposing roles in pancreatic cancer via ferroptosis and pyroptosis. Co-author DOI 10.1007/s10565-025-10096-6↗
  6. Hyaluronic acid and its role in pancreatic cancer: Mechanisms of tumor progression, drug resistance, and therapeutic targeting. Co-author DOI 10.1016/j.phrs.2025.107958↗
  7. Immunosenescence-Related Gene MAFF is Involved in Immune Regulation and Malignant Progression in Pancreatic Adenocarcinoma. Co-author DOI 10.1186/s12575-025-00278-1↗
  8. Lactate-associated gene MCU promotes the proliferation, migration, and invasion of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-025-14319-1↗
  9. Elemene Injection Suppresses Pancreatic Cancer Progress through Regulating Cell Adhesion: A Research Based upon Network Pharmacology and Verification Test. Co-author DOI 10.2174/0109298673351591241114101143↗
  10. Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12920-023-01530-x↗
  11. Overexpression of pyruvate dehydrogenase phosphatase 1 promotes the progression of pancreatic adenocarcinoma by regulating energy-related AMPK/mTOR signaling. Co-author DOI 10.1186/s13578-020-00457-5↗
  12. Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer. Co-author DOI 10.7150/thno.43093↗
  13. Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer. Co-author DOI 10.3390/cancers11060874↗
  14. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer. Co-author DOI 10.1155/2017/6012810↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xinghe Liao · 4 shared papers, 2025–2026 · strength 1.22
  2. Lianyu Chen · 4 shared papers, 2020–2025 · strength 1.01
  3. Fenglin Zhang · 3 shared papers, 2025–2026 · strength 0.91
  4. Wenxun Cai · 3 shared papers, 2025 · strength 0.88
  5. Hao Chen · 3 shared papers, 2025–2026 · strength 0.87
  6. Ping Li · 2 shared papers, 2025–2026 · strength 0.78
  7. Yuhang Chen · 2 shared papers, 2025 · strength 0.55
  8. Christiane J. Bruns · 4 shared papers, 2017–2026 · strength 0.50
  9. Yue Zhao · 4 shared papers, 2017–2026 · strength 0.50
  10. Zhefang Wang · 3 shared papers, 2019–2026 · strength 0.43
  11. Chien‐shan Cheng · 2 shared papers, 2020–2025 · strength 0.42
  12. Hao Chen · 1 shared paper, 2026 · strength 0.36
  13. Qiongzhu Dong · 2 shared papers, 2020–2026 · strength 0.35
  14. Ping Li · 1 shared paper, 2026 · strength 0.32
  15. zhou zhou · 1 shared paper, 2026 · strength 0.32
  16. Haibo Cheng · 1 shared paper, 2026 · strength 0.27
  17. Hao-jie Du · 1 shared paper, 2026 · strength 0.27
  18. Felix Popp · 3 shared papers, 2017–2020 · strength 0.25
  19. Alexander Quaas · 1 shared paper, 2026 · strength 0.25
  20. Maximilian Reichert · 1 shared paper, 2026 · strength 0.25
  21. Hana Algül · 1 shared paper, 2026 · strength 0.25
  22. Linjia Peng · 1 shared paper, 2023 · strength 0.22
  23. Yujie Li · 1 shared paper, 2023 · strength 0.22
  24. Hao Chen · 1 shared paper, 2023 · strength 0.22
  25. Ke Zhang · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.